Evidence map›Paper›PMID 23300758›Full record

ArticlePloS one2012

Using bacteria to determine protein kinase specificity and predict target substrates.

Michael F Chou, Sladjana Prisic, Joshua M Lubner, George M Church, Robert N Husson, Daniel Schwartz

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. The Okur-Chung Neurodevelopmental Syndrome Mutation CK2Frontiers in molecular biosciences · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cushing's syndrome mutant PKAFEBS letters · 2017
    Article
  12. Protein networks and activation of lymphocytes.Current opinion in immunology · 2015
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michael F ChouDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
Sladjana Prisic
Joshua M Lubner
George M Church
Robert N Husson
Daniel Schwartz

Funding

Chemical Inhibitors to Define an Essential M. Tuberculosis Signaling NetworkR01AI099204 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI HUSSON, ROBERT N · 2012 to 2016
$6.1M
Characterization of M. tuberculosis kinases PknA &PknBR01AI059702 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI HUSSON, ROBERT N · 2004 to 2008
$1.9M
Signal Transduction and Latency in M. tuberculosisR21AI051707 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI HUSSON, ROBERT N · 2002 to 2003
$469k
NIAID NIH HHS R01 AI059702NIAID NIH HHS R01 AI099204NIAID NIH HHS R21 AI051707
6 · The paper itself

Abstract

The identification of protein kinase targets remains a significant bottleneck for our understanding of signal transduction in normal and diseased cellular states. Kinases recognize their substrates in part through sequence motifs on substrate proteins, which, to date, have most effectively been elucidated using combinatorial peptide library approaches. Here, we present and demonstrate the ProPeL method for easy and accurate discovery of kinase specificity motifs through the use of native bacterial proteomes that serve as in vivo libraries for thousands of simultaneous phosphorylation reactions. Using recombinant kinases expressed in E. coli followed by mass spectrometry, the approach accurately recapitulated the well-established motif preferences of human basophilic (Protein Kinase A) and acidophilic (Casein Kinase II) kinases. These motifs, derived for PKA and CK II using only bacterial sequence data, were then further validated by utilizing them in conjunction with the scan-x software program to computationally predict known human phosphorylation sites with high confidence.

Indexed as

Protein Processing, Post-TranslationalAmino Acid MotifsAmino Acid SequenceCasein Kinase IIConsensus SequenceCyclic AMP-Dependent Protein KinasesEscherichia coliEscherichia coli ProteinsHumansHydrophobic and Hydrophilic InteractionsMolecular Sequence DataPeptide LibraryPhosphorylationRecombinant ProteinsROC CurveSequence Analysis, ProteinCasein Kinase IICyclic AMP-Dependent Protein KinasesEscherichia coli ProteinsPeptide LibraryRecombinant Proteins

Identifiers

PMID23300758
PMCPMC3530509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.